Tata Chemicals Q2FY26: Revenue ₹3,877 Cr, EBITDA ₹537 Cr
Tata Chemicals Q2FY26: Consolidated revenue at ₹3,877 Cr, down 3% YoY; EBITDA at ₹537 Cr. Standalone revenue up 19% YoY at ₹1,204 Cr, with EBITDA up 67% at ₹240 Cr.
The results indicate a mixed performance with standalone growth offset by consolidated declines, suggesting a moderate impact on the company.
The announcement presents a mix of positive and negative financial results. While standalone performance improved, consolidated results showed a decline in revenue and EBITDA.
* Tata Chemicals announced its financial results for the second quarter and half-year ended September 30, 2025. * Consolidated revenue from operations for the quarter stood at ₹3,877 crore, down by 3% compared to Q2FY25. * EBITDA was ₹537 crore, compared to ₹618 crore in Q2FY25. * Profit After Tax (before exceptional items and NCI) was ₹219 crore, compared to ₹267 crore for Q2FY25. * Net debt as on September 30, 2025, stood at ₹5,583 crore (excluding lease of ₹776 crore). * Standalone revenue from operations was ₹1,204 crore, up by 19% compared to Q2FY25. * Standalone EBITDA was ₹240 crore, up by 67% compared to Q2FY25. * Standalone Profit After Tax from continuing operations was ₹178 crore, up by 80% compared to Q2FY25. * Consolidated revenue from operations for H1FY26 was ₹7,596 crore, down by 2% compared to H1FY25. * Consolidated EBITDA was ₹1,186 crore, compared to ₹1,192 crore in H1FY25. * Consolidated Profit After Tax (before exceptional items and NCI) was ₹535 crore compared to ₹442 crore for H1FY25. * Standalone revenue from operations for H1FY26 was ₹2,373 crore, up by 15% compared to H1FY25. * Standalone EBITDA was ₹510 crore, up by 35% compared to H1FY25. * Standalone Profit After Tax from continuing operations was ₹485 crore, up by 37% compared to H1FY25. * R. Mukundan, Managing Director & CEO, commented that soda ash markets continue to be oversupplied, and prices remained weak during Q2FY26, expecting the market to remain range-bound in the medium term.
What to do with a filing like this
Tata Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tata Chemicals Limited. Read the original for the full detail.